FDA Clearance Tracker · K250445
Fast Warm - NX
Last checked: Nov 19, 2026Latest source record: Sep 12, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Sep 12, 2025
Substantially Equivalent
Time to decision
210 days
Received Feb 14, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K250445
- Device name
- Fast Warm - NX
- Applicant
- Fujifilm Irvine Scientific
- Applicant location
- Santa Ana, CA
- Received
- Feb 14, 2025
- Decided
- Sep 12, 2025
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Media, Reproductive (MQL)
- Device class
- Class II
- Regulation
- 21 CFR 884.6180
- Specialty
- Obstetrics & Gynecology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code MQL. The earliest in FDA's data is K864524, decided Feb 2, 1987.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K250445
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Fujifilm Irvine Scientific
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K241341 · Decided Sep 26, 2024 · 136 days after receipt
Device type: Labware, Assisted Reproduction (MQK) · Obstetrics & Gynecology
K233764 · Decided Apr 24, 2024 · 152 days after receipt
Device type: Media, Reproductive (MQL) · Obstetrics & Gynecology
K231804 · Decided Nov 9, 2023 · 142 days after receipt
Device type: Media, Culture, Ex Vivo, Tissue And Cell (NDS) · GI, Urology & Nephrology
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.